Article Highlights: Cut Cravings With Saffron
- Stress, anxiety, or depression can induce a biomolecular mechanism that causes the comfort-food cravings and compulsive snacking that sabotage many weight-loss programs.
- Normal brain reward pathways are disrupted by this unbalancing of hormones and neurotransmitters, resulting in the feed-feedback cycle that causes food cravings and emotion-based snacking.
- A study recently found this negative cycle, known as reactional hyperphagia, to be virtually identical to the mechanism underlying drug addiction.(10)
- An extract of saffron (Crocus sativus) uniquely targets this appetite dysregulation at the neurotransmitter level and inhibits the snacking compulsion.
- Placebo-controlled studies found that 176.5 mg a day of a proprietary saffron extract decreased snacking events by an average of 55%!(1,2)
Dieting alone is ineffective for most overweight adults, and even those who successfully lose weight often gain it back soon afterward. The snacking impulse is a common source of weight-loss sabotage.
Scientists have discovered that the inability to lose weight often stems from the powerful effects of emotional stress and depression on the brain. This chemically triggers strong cravings for comfort foods and snacks. If this is your problem, you may be suffering from an abnormal increased appetite for consumption of food known as reactional hyperphagia. Simply put, emotional stress causes brain-chemical and hormonal changes that decrease feelings of satiety (fullness) and promote – and “reward” – the compulsion to snack, especially on comfort foods.
In this article, you will learn how a saffron extract targets appetite dysregulation at the neurotransmitter level, inhibiting the compulsion-reward cycle and reducing the snacking impulse.
In one small 4-week study, a decrease in between-meal snacking was reported by women taking a proprietary extract of saffron!(1) And in another human study using the same extract, the overall number of snacking episodes was reduced within 8 weeks – by 55%!(2)
The restrictions of dieting often generate stress, anxiety, and depression. In some people, the resultant changes in neurotransmitters and hormones create an overwhelming impulse to seek out what scientists call “highly palatable,” or comfort, foods.(3-12)
Surrendering to this impulse then triggers brain activity associated with reward, which temporarily alleviates stress, anxiety, and depression. This off-diet eating may result in weight gain, guilt, and renewed dieting – all stressors that perpetuate the cycle.(3-10,13)
If this sounds like your dieting pattern, your brain and hormones may be sabotaging your weight-loss attempts, and leaving you with undeserved guilt and frustration.
You may have stress-induced reactional hyperphagia, which is defined as the abnormal increased appetite for consumption of food.(8,13,14)
Many people who are not dieting still experience emotional stress from other sources and experience the same compulsive-addictive form of emotion-based overeating. This “stress-snacking” feedback cycle can eventually lead to weight gain and more stress. It is no coincidence that high obesity rates have become an escalating health concern during this era of chronically high stress levels.(3-14)
To maintain a healthy weight comfortably, it is important to interrupt and block this sabotaging hyperphagic cycle.
The good news is that scientists have developed a botanical formulation that helps break this pattern.
Saffron is a spice that is constituted from the red stigmas of Crocus sativus L. In randomized, placebo-controlled research on humans, a standardized and proprietary extract of saffron reduced the desire to snack, diminished the craving for comfort foods, produced satiety, and facilitated weight loss—without any stimulant effect, side effect risk, or unrealistic level of continuous willpower.
The ‘Feed-Feedback’ Cycle
Many weight-loss drugs that are meant to reduce appetite are dangerous. For example, phenylpropanolamine is associated with hemorrhagic stroke.(17)
However, a particular extract of saffron appears to be unique in its ability to target the neurochemical pathways underlying the craving for comfort foods and the compulsion to eat between meals (reactional hyperphagia).
Growing research has been shedding light on these pathways of compulsive snacking, and how they set up a feed-feedback cycle that is essentially stress, stress-relief, stress, stress-relief, and so on.
Early research showed that the food restrictions of weight-loss diets are major sources of stress and anxiety. Some people respond to this greater stress by developing cravings for specific (comfort) foods associated with stress relief, making them more susceptible to obesity than others.(3-6)
A study in 2007 reviewed earlier research on both animals and humans, and proposed a theory termed Reward Based Stress Eating. Evidence indicated that during stress, cortisol (a glucocorticoid), together with the body’s reward circuitry, causes dysregulation of the finely tuned balance of appetite control. Cravings increase stress, which triggers an increase in the reward value of highly palatable (comfort) food. The result is an increased intake of high-calorie snack food, and a greater accumulation of visceral fat.(8)
In a landmark study published in 2010, researchers found that the dysregulated brain reward pathways that trigger drug and alcohol addiction are identical to the biomolecular mechanisms behind comfort-food cravings.(10)
In a 2011 study, scientists discussed the circular relationship between hyperphagia (increased appetite), comfort food intake, and obesity. They suggested that in some individuals, the presence of this feed-feedback cycle at an early age may lead directly to obesity later in life. They further suggested that obesity itself may increase signaling along inflammatory, oxidative, and mitochondrial stress pathways – altering normal reward functions and promoting compulsive snacking.(18)
On the heels of these findings, and with obesity at epidemic levels, scientists searched in earnest for a way to safely break the feed-feedback cycle.
Targeting the Biochemistry of Appetite
In the quest for a novel intervention to block reactional hyperphagia and the cycle of compulsive snacking, attention quickly turned to the active components in saffron – and for a number of good reasons.
First, now that dieting and stress had been found to increase the reward value of comfort food for many people,(8) it was natural to examine agents believed to modulate stress in order to identify those that might beneficially affect the appetite and snacking impulse. In ancient medical systems, saffron has traditionally been used to reduce anxiety, relieve stress, and enhance mood.(19)
Second, no effective FDA-approved drug is available that can regulate the neurochemistry of appetite without substantially dangerous side effects,(20) which have been found to include pulmonary hypertension and heart valve disease.(21) Scientists realized that – if verified to be effective in inhibiting the snacking compulsion in placebo-controlled studies on humans – saffron would constitute a safe and natural alternative.
Third, neurotransmitter imbalance, particularly low levels of serotonin, has been shown to increase vulnerability to overeating, food cravings, and depression.(22) A number of journal-published studies had shown that safranal and crocin, active constituents of saffron, have demonstrated effects comparable to prescription medications in mitigating the symptoms of depression.(23-25) One of the most commonly prescribed group of anti-depressant medications are the selective serotonin reuptake inhibitors (SSRI), which are well known to produce a number of adverse side effects, including sedation, weight gain, sexual dysfunction, and suicidal thoughts.(26-28) This improved serotonin-enhancing activity suggested that saffron may be a safe and potent weapon to break the feed-feedback cycle and inhibit reactional hyperphagia – for several reasons:
- Stress increases levels of cortisol, which can cause dysregulation of appetite – serotonin, through serotonergic neurons, regulates appetite.(12)
- Stress activates the entire HPA axis, which is involved in the feed-feedback cycle – and serotonin regulates and normalizes HPA activity.(29)
- Compulsive snacking and reactional hyperphagia are strongly related to depression, anxiety, and mood – and serotonin can improve all of these snacking-related emotional states.(30)
- Stress increases levels of glucocorticoids, which can diminish the transport efficiency of serotonin, in turn lowering serotonin activity and negatively affecting both mood and appetite(31)-promoting serotonin activity would be a natural way to counter this transport effect and favorably modulate both mood and appetite.
In subsequent animal and human studies, saffron extracts proved highly effective in safely managing depression and anxiety(32-35) – the same emotional disorders that trigger reactional hyperphagia.
However, this constituted only an indirect link between saffron and modulation of the snacking compulsion. Scientists still needed to prove that saffron’s powerful ability to modulate stress would in turn translate into a significant reduction in hyperphagic snacking, both in terms of desire and behavior.
For the gold standard in scientific proof, this would demand investigating the effects of saffron extract – specifically on snacking desire and frequency-by conducting randomized, placebo-controlled, double-blind studies on humans.
Inhibiting the Snacking Impulse in Humans
To corroborate that a proprietary extract of saffron targets the neurochemistry at the root of compulsive eating, scientists first conducted a small placebo-controlled, double-blind pilot study on a small group of 16 women. Half of the women were given the proprietary saffron (Crocus sativus) daily for extract for 4 weeks, while the other half took placebo.
Remarkably, all of the women taking the saffron extract decreased their between-meal snacking, while women taking the placebo experienced no improvement! Equally noteworthy, the women in the saffron group reported decreased feelings of hunger at lunch and dinner. There was an average weight loss, largely in the form of fat from the thighs, of 3.63 pounds.(1)
Following these findings, scientists launched a full-scale, randomized, double-blind, placebo-controlled clinical trial, enlisting 60 mildly overweight, female volunteers ranging in age from 25 to 45. This time, however, at least half of the women selected suffered from compulsive between-meal snacking behavior, although participants were not assessed specifically for their level of anxiety or stress. Women were excluded if they had any history of cancer, diabetes, gastric surgery, pathological eating disorders (such as anorexia and bulimia nervosa), abnormal liver or kidney function or were currently using any medications (such as antidepressants) or supplements that might interfere with the results.
As before, half of the subjects were given daily doses of 176.5 mg of patented saffron extract—but this time, for a full 8 weeks – while the others took an identical-looking placebo. All subjects were instructed to otherwise maintain their normal dietary and lifestyle habits, and all between-meal food consumption was recorded.
The saffron extract significantly reduced the frequency of snacking events to a degree that the journal-published study described as “most striking.” At the beginning of the study, both groups indulged in an average of 12 between-meal snacks per week. After 8 weeks, the number of snacking events for the placebo group fell somewhat to 8.9 per week, a decrease of 28%. By comparison, between-meal snacks for the saffron group decreased to just 5.8 per week, a snacking decrease, over 8 weeks—of 55%!(2)
The reduction in snacking events among the saffron-extract group paralleled an increase in satiety sensation. These women reported significantly reduced feelings of hunger before meals, and a reduced feeling of the “need” to snack between meals. These saffron subjects experienced significantly greater feelings of alertness and energy.
The key objective of the study was to assess the effect of saffron extract on the frequency of snacking, and because the volunteers were only mildly overweight, substantial weight loss was not expected. Still, the increased satiety and 55% decreased snacking had an effect on weight. The saffron group experienced an average weight loss of over 2 pounds during this 8-week period of eating normally!(2)
While no conclusions could be reached regarding the mechanism of action for saffron extract, the study team did note that new saffron research data suggests that the benefits could be related to saffron’s impact on mild-moderate anxiety.(2) This finding was upheld in the current study when during the administration of a global health survey at the end of supplementation, those in the saffron group reported feeling significantly more alert and energetic than those in the placebo group. This same trend continued on follow up several weeks after completion of supplementation.(2) This modest weight loss shows why more than just reduced calorie consumption is needed to produce meaningful fat loss. Taking standardized green coffeeberry extract before each meal resulted in (17.6) pounds of weight loss in a study published in 2012.(36)
Scientists have discovered that there is a stress-induced mechanism behind the comfort-food cravings and compulsive snacking that sabotage many weight-loss programs.
Unbalanced hormones and neurotransmitters disrupt the normal brain reward pathways. The result is an induced feed-feedback cycle, known as reactional hyperphagia, which causes food cravings.
A study recently found this cycle to be all but identical to the mechanism underlying drug addiction.(10)
A proprietary extract of saffron (Crocus sativus) uniquely targets this appetite dysregulation at the neurotransmitter level, inhibiting the snacking compulsion.
Placebo-controlled studies found that a daily dose of 176.5 mg of a proprietary saffron extract decreased the average number of snacking incidents by 55% and decreased between-meal snacking—for all of the women taking saffron!(1,2)
1.Noury J, Bourges C. Enquête sur l’impact du complément alimentaire SATIEREAL chez des femmes ayant une tendance à l’hyperphagie réflexe non pathologique. Nutraveris. 2006; unpublished study.
2. Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res. 2010 May;30(5):305-13.
3. Greeno CG, Wing RR. Stress-induced eating. Psychol Bull. 1994 May;115(3):444-64.
4. Lattimore P, Caswell N. Differential effects of active and passive stress on food intake in restrained and unrestrained eaters. Appetite. 2004 Apr;42(2):167-73.
5. Polivy J, Herman CP. Distress and eating: why do dieters overeat? Int J Eat Disord. 1999 Sep;26(2):153-64.
6. Laitinen J, Ek E, Sovio U. Stress-related eating and drinking behavior and body mass index and predictors of this behavior. Prev Med. 2002 Jan;34(1):29-39.
7. Pecoraro N, Reyes F, Gomez F, Bhargava A, Dallman MF. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology. 2004 Aug;145(8):3754-62.
8. Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007;91:449-58.
9. Warne JP. Shaping the stress response: interplay of palatable food choices, glucocorticoids, insulin and abdominal obesity. Mol Cell Endocrinol. 2009 Mar 5;300(1-2):137-46.
10. Johnson PM, Kenny, PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010 May;13(5):635-41.
11. Dallman MF, Pecoraro N, Akana SF, et al. Chronic stress and obesity: a new view of “comfort food.” PNAS USA. 2003;100: 11696-701.
12. Bjorntorp P, Rossner S, Udden J. “Consolatory eating” is not a myth. Stress-induced increased cortisol levels result in leptin-resistant obesity. Lakartidningen. 2001;98:5458-61.
13. Alsiö J, Olszewski PK, Levine AS, Schiöth HB. Feed-forward mechanisms: Addiction-like behavioral and molecular adaptations in overeating. Front Neuroendocrinol. Epub 2012 Jan 28.
14. Available at: http://www.hyperphagia.com/hyperphagia-causes/. Accessed March 21, 2012.
15. Centers for Disease Control and Prevention (CDC). Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997. MMWR. Morbidity and mortality weekly report 46. 1997;(45):1061-6.
16. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. NEJM. 1997 Aug 28;337(9):581-8.
17. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke.NEJM. 2000 Dec;343(25): 1826-32.
18. Berthoud HR, Lenard NR, Shin AC. Food reward, hyperphagia, and obesity. Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1266-77.
19. Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 2009 Jun;23(6):768-74.
20. Rodgers RJ, Holch P, Tallett AJ. Behavioural satiety sequence (BSS): Separating wheat from chaff in the behavioural pharmacology of appetite. Pharmacol Biochem Behav. 2010 Nov;97(1):3-14.
21. Connolly HM, Crary JL, McGoon MD,et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997 Aug 28;337(9):581-8.
22. Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regulation. Hum Reprod. 1997 Jun;12(6):1142-51.
23. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med. 2004 Sep 2;4:12.
24. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol. 2005 Feb 28;97(2):281-4.
25. Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):439-42.
26. Cascade E, Kalali AH, Kennedy SH. Real-world data on SSRI antidepressant side effects. Psychiatry (Edgmont). 2009 Feb;6 (2):16-8.
27. Zimmerman M, Galione JN, Attiullah N, et al. Underrecognition of clinically significant side effects in depressed outpatients. J Clin Psychiatry. 2010 Apr;71(4):484-90.
28. Lee KU, Lee YM, Nam JM, et al. Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting. Psychiatry Investig. 2010 Mar;7(1):55-9.
29. Spencer RL, Hutchinson KE. Alcohol, Aging, and the Stress Response. Alcohol Res & Health. Winter 1999.
30. O’Rourke DA, Wurtman JJ, Wurtman RJ, et al. Aberrant snacking patterns and eating disorders in patients with obsessive compulsive disorder. J Clin Psychiatry. 1994 Oct;55(10):445-7.
31. Slotkin TA, McCook EC, Ritchie JC, Seidler FJ. Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol Psychiatry. 1996 Oct1;40(7):576-84.
32. Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 2009 Jun;23(6):768-74.
33. Wang Y, Han T, Zhu Y, et al. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med. 2010 Jan;64(1):24-30.
34. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006 Nov;13(9-10):607-11.
35. Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA, Sakellaridis N. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine. 2008 Dec;15(12):1135-9.
36. Vinson JA, Burnham BR, Nagendran MV. Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes. 2012;5:21-7.
37. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Accessed May 1, 2012.
38. Abdullaev FI. Plant-derived agents against cancer. In: Gupta SK, ed. Pharmacology and Therapeutics in the New Millennium. New Delhi: Narosa Publishing House; 2001:345-54.
39. Escribano J, Alonso GL, Coca-Prados M, Fernandez JA. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett. 1996;100(1-2):22-30.
40. Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK, Cordopatis P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res. 2007;27(1A):357-62.
41. Abdullaev JF, Caballero-Ortega H, Riverón-Negrete L, et al. In vitro evaluation of the chemopreventive potential of saffron. Rev. Invest. Clin. 2002;54(5):430-6.
42. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med. 2002;227:20-5.
43. Nair SC, Salomi MJ, Pannikar. B, Pannikar KR. Modulatory effects of the extracts of saffron and Nigela sativa against cisplatinum induced toxicity in mice. J Ethnopharmacol. 1991;31:75-83.
44. el Daly ES. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Belg. 1998 Mar-Apr;53(2):87-93; discussion 93-5.
45. Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. Jour Pharm Pharmaceut Sci. 2005;8(3):394-9.
46. Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res. 2005 Nov;19(11):997-1000.
47. Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, Margarity M. Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav Brain Res. 2011 Jun 1;219(2):197-204.
48. Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res. 2005 Feb;19(2):148-51.
49. Fetissov SO, Meguid MM. Serotonin delivery into the ventromedial nucleus of the hypothalamus affects differently feeding pattern and body weight in obese and lean Zucker rats. Appetite. 2010 Apr;54(2):346-53.
50. Yamauchi M, Tsuruma K, Imai S, et al. Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur J Pharmacol. 2011 Jan 10;650(1):110-9.
51. Maccarone R, Di Marco S, Bisti, S. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest Ophth Visual. 2008 Mar;49(3):1254-61.
52. Falsini B, Piccardi M, Minnella A, et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6118-24.
53. Moghaddasi MS. Saffron chemicals and medicine usage. Jour Med Plants Res. 2010 Mar;4(6):427-30.
54. Winterhalter P, Straubinger M. Saffron-renewed interest in an ancient spice. Food Rev Int. 2000;16(1):39-59.
55. Verma RS, Middha D. Analysis of saffron (Crocus sativus L. stigma) components by LC–MS–MS. Chromatographia. 2010;71 (1-2):117-23.
56. Pfander H, Schurtenberge H. Biosynthesis of C20-carotenoids in Crocus sativus. Phytochemistry. 1982;21:1039-42.
57. Himeno H, Sano K. Synthesis of crocin, picrocrocin and safranal by saffron stigma-like structures proliferated in vitro. Agric Biol Chem. 1987;51(9):2395-400.
58. Rödel W, Petrzika M. Analysis of the volatile components of saffron. J High Res Chromatogr. 1991;14:771-4.
59. Iborra JL, Castellar MR, Cánovas M, Manjón A. TLC preparative purification of picrocrocin, HTCC and crocin from saffron. J Food Sci. 1992;3:714-6.
60. Iborra JL, Castellar MR, Cánovas M, Manjón A. Picrocrocin hydrolysis by immobilized-glucosidase. Biotechnol Lett. 1992;14(6):475-80.
61. Narasimhan H, Chand H, Rajalakshmi D. Saffron, quality evaluation by sensory profile and gas chromatography. J Food Qual. 1992;15:303-14.
62. Sujata V, Ravishankar GA, Venkataraman LV. Methods for the analysis of the saffron metabolites crocin, crocetind, picrocrocin and safranal for the determination of the quality of spice using thin-layer chromatography, HPLC and GC. J Chromatogr. 1992;624(1-2):497-502.
63. Iborra JL, Castellar MR, Cánovas M, Manjón A. Analysis of a packed-bed reactor for hydrolysis of picrocrocin by immobilized ?-glucosidase. Enzyme Microb Technol. 1993;15:780-4.
64. Castellar MR, Montijano H, Manjón A, Iborra JL. Preparative high-performance liquid chromatographic purification of saffron secondary metabolites. J Chromatogr. 1993;648:187-90.
65. Tarantilis PA, Polissiou M, Mentzafos D, Terzis A, Manfait M. The structure of dimethylcrocetin. J Chem Crystallogr. 1994;24(11):739-42.
66. Tarantilis PA, Polissiou M, Manfait M. Separation of picrocrocin, cis-trans-crocins and safranal of saffron using high-performance liquid chromatography with photodiode-array detection. J Chromatogr A. 1994;664:55-61.
67. Tarantilis PA, Tsoupras G, Polissiou M. Determination of saffron (Crocus sativus L.) components in crude plant extract using high-performance liquid chromatography-UV-visible photodiode-array detection-mass spectrometry. J Chromatogr A. 1995;699(1-2):107-18.
68. Corti P, Mazzei E, Ferri S, Franchi GG, Dreassi E. High-performance thin layer chromatographic quantitative analysis of picrocrocin and crocetin, active principles of saffron (Crocus sativus L.-Iridaceae): a new method. Phytochem Anal. 1996;7:201-3.
69. Saito K, Utsumi Y. Enhancing effect of UV light on accumulation of carthamine in dyer’s saffron florets. Z Naturfosch [C]. 1996;51 (9-10):667-70.
70. Straubinger M, Jezussek M, Waibel R, Winterhalter P. Novel glucosidic constituents from saffron. J Agric Food Chem. 1997;45(5):1678-81.
71. Straubinger M, Bau B. Eckstein S, Fink M, Winterhalter P. Identification of novel glycosidic aroma precursors in saffron (Crocus sativus L.). J Agric Food Chem. 1998;46(8):3238-43.
72. Alonso GL, Salinas MR, Esteban-Infantes FJ, Sánchez-Fernández MA. Determination of safranal from saffron (Crocus sativus L.) by thermal desorption-gas chromatography. J Agric Food Chem. 1996;44:185-88.
73. Alonso GL, Salinas MR, Garijo J. Method to determine the authenticity of aroma of saffron (Crocus sativus L.). J Food Prot. 1998;61(11):1525-8.
74. Tarantilis PA, Polissiou M. Isolation and identification of the aroma components from saffron (Crocus sativus L.). J Agric Food Chem. 1997;45:459-62.
75. Li N, Lin G, Kwan YW, Min D. Simultaneous quantification of five major biologically active ingredients of saffron by high-performance liquid chromatography. J Chromatogr A. 1999;849(2):349-55.
76. Lozano P, Castellar MJ, Simancas MJ, Iborra JL. Quantitative high-performance liquid chromatographic method to analyze commercial saffron (Crocus sativus L.) products. J Chromatogr A. 1999;830:477-83.
77. Lozano P, Delgado D, Gomez D, Rubio M, Iborra JL. A non-destructive method to determine the safranal content of saffron (Crocus sativus L.) by supercritical carbon dioxide extraction combined with high-performance liquid chromatography and gas chromatography. J Biochem Biophys Methods. 2000;4328513-N(1-3):367-78.
78. Bhargava V. Medicinal uses and pharmacological properties of Crocus sativus Linn (Saffron). Int J Pharm Pharm Sci. 2011;3(Suppl 3):22-6.